Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Locally Advanced Non-small Cell Lung Cancer
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      OA02.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      OA02.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      OA02.03 - Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial

      12:02 - 12:12  |  Presenter: Marta Casarrubios

      • Abstract

      Loading...

    • +

      OA02.04 - Multimodal Management of T4 N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules

      12:12 - 12:22  |  Presenter: Arvind Kumar

      • Abstract

      Loading...

    • +

      OA02.05 - Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study

      12:22 - 12:32  |  Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      OA02.06 - Discussant

      12:32 - 12:42  |  Presenter: Linda Martin

      • Abstract

      Loading...

    • +

      OA02.07 - Live Q&A

      12:42 - 13:00

      • Abstract

      Loading...

  • +

    IS11 - Industry Symposium Sponsored by Amgen Inc.: Driving Advancements in the Treatment of Lung Cancer

    • 13:15 - 14:15
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Industry Symposium
    • Track: N/A
    • +

      Session Moderator

      13:15 - 13:15  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      IS11.01 - Welcome and Introduction to Innovative Treatments for New Targets in Lung Cancer

      13:15 - 13:30  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

  • +

    OA03 - Molecular Targeted Treatments

    • 14:30 - 15:40
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

      14:42 - 14:52  |  Presenter: Adrian Sacher

      • Abstract

      Loading...

  • +

    MA05 - Immune Landscape and Molecular Profiling of Lung Cancer

    • 15:45 - 16:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      15:45 - 15:45  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      Session Moderator

      15:45 - 15:45  |  Presenter: Tina Cascone

      • Abstract

      Loading...

    • +

      MA05.01 - Session Introduction

      15:45 - 15:46  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      MA05.02 - Session Introduction

      15:46 - 15:47  |  Presenter: Tina Cascone

      • Abstract

      Loading...

    • +

      MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer

      15:47 - 15:52  |  Presenter: Wenbin Li

      • Abstract

      Loading...

    • +

      MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC

      15:52 - 15:57  |  Presenter: Max Wilhelm Backman

      • Abstract

      Loading...

    • +

      MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment

      15:57 - 16:02  |  Presenter: Xiaoli Liu

      • Abstract

      Loading...

    • +

      MA05.06 - Discussant

      16:02 - 16:12  |  Presenter: Fabio Pagni

      • Abstract

      Loading...

    • +

      MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping

      15:57 - 16:02  |  Presenter: Yuchen Han

      • Abstract

      Loading...

    • +

      MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History

      16:17 - 16:22  |  Presenter: Jennifer A. Marks

      • Abstract

      Loading...

    • +

      MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma

      16:22 - 16:27  |  Presenter: Harry Lengel

      • Abstract

      Loading...

    • +

      MA05.10 - Discussant

      16:27 - 16:37  |  Presenter: Giulia Pasello

      • Abstract

      Loading...

    • +

      MA05.11 - Live Q&A

      16:37 - 16:45

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases

      Presenter: Ernest Nadal

      • Abstract

      Loading...

  • +

    EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
    • +

      EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC

      Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer

      Presenter: Stephen V. Liu

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity

      Presenter: Francesco Passiglia

      • Abstract

      Loading...

  • +

    P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      P1.16-04 - Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors

      Presenter: Niels Reinmuth

      • Abstract

      Loading...

  • +

    OA12 - Novel and Combination Strategies for SCLC

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer

      16:22 - 16:32  |  Presenter: Hossein Borghaei

      • Abstract

      Loading...

  • +

    P2.07 - Pathology - Tumour Genomics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Pathology - Tumour Genomics
    • +

      P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC

      Presenter: Susana Hernandez

      • Abstract

      Loading...